NO20023385L - Etanolopplösning av (-)-cis-2-(2-klorofenyl)-5,7-dihydroksy- 8(4R-(3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on - Google Patents

Etanolopplösning av (-)-cis-2-(2-klorofenyl)-5,7-dihydroksy- 8(4R-(3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on

Info

Publication number
NO20023385L
NO20023385L NO20023385A NO20023385A NO20023385L NO 20023385 L NO20023385 L NO 20023385L NO 20023385 A NO20023385 A NO 20023385A NO 20023385 A NO20023385 A NO 20023385A NO 20023385 L NO20023385 L NO 20023385L
Authority
NO
Norway
Prior art keywords
benzopyran
piperidinyl
chlorophenyl
dihydroxy
cis
Prior art date
Application number
NO20023385A
Other languages
English (en)
Other versions
NO20023385D0 (no
NO322626B1 (no
Inventor
Kurt M Kesseler
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20023385D0 publication Critical patent/NO20023385D0/no
Publication of NO20023385L publication Critical patent/NO20023385L/no
Publication of NO322626B1 publication Critical patent/NO322626B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20023385A 2000-01-18 2002-07-12 Hydroklorid-etanol-solvatform av (-)-cis-2-(2-klorfenyl)-5,7-dihydroksy-8[4R-(3S-hydroksy-1-metyl)piperidinyl]-4H-1-benzopyran-4-on, fremgangsmate for fremstilling derav og anvendelse derav ved behandling av cancer. NO322626B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48781500A 2000-01-18 2000-01-18
PCT/US2001/000520 WO2001053294A1 (en) 2000-01-18 2001-01-08 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one

Publications (3)

Publication Number Publication Date
NO20023385D0 NO20023385D0 (no) 2002-07-12
NO20023385L true NO20023385L (no) 2002-08-27
NO322626B1 NO322626B1 (no) 2006-11-06

Family

ID=23937213

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023385A NO322626B1 (no) 2000-01-18 2002-07-12 Hydroklorid-etanol-solvatform av (-)-cis-2-(2-klorfenyl)-5,7-dihydroksy-8[4R-(3S-hydroksy-1-metyl)piperidinyl]-4H-1-benzopyran-4-on, fremgangsmate for fremstilling derav og anvendelse derav ved behandling av cancer.

Country Status (26)

Country Link
EP (1) EP1252155B1 (no)
JP (1) JP2003520798A (no)
KR (1) KR100825530B1 (no)
CN (1) CN1395577A (no)
AR (1) AR027226A1 (no)
AT (1) ATE284400T1 (no)
AU (1) AU2001230869A1 (no)
BR (1) BR0107724A (no)
CA (1) CA2397594C (no)
CZ (1) CZ301235B6 (no)
DE (1) DE60107652T2 (no)
DK (1) DK1252155T3 (no)
EA (1) EA005182B1 (no)
ES (1) ES2228800T3 (no)
HU (1) HU225155B1 (no)
IL (2) IL150643A0 (no)
MX (1) MXPA02006965A (no)
NO (1) NO322626B1 (no)
NZ (1) NZ520281A (no)
PL (1) PL201690B1 (no)
PT (1) PT1252155E (no)
SI (1) SI1252155T1 (no)
SK (1) SK287216B6 (no)
TW (1) TWI293072B (no)
WO (1) WO2001053294A1 (no)
ZA (1) ZA200205640B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102466192B1 (ko) 2016-08-23 2022-11-14 에자이 알앤드디 매니지먼트 가부시키가이샤 간세포성 암종의 치료를 위한 조합 요법
WO2018170447A1 (en) 2017-03-16 2018-09-20 Eisai R&D Management Co., Ltd. Combination therapies for the treatment of breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (no) * 1986-04-11 1989-02-04 Hoechst India
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
PT1252155E (pt) 2005-04-29
ES2228800T3 (es) 2005-04-16
ZA200205640B (en) 2003-11-26
PL355992A1 (en) 2004-05-31
IL150643A (en) 2009-08-03
CZ301235B6 (cs) 2009-12-16
ATE284400T1 (de) 2004-12-15
AR027226A1 (es) 2003-03-19
NO20023385D0 (no) 2002-07-12
KR100825530B1 (ko) 2008-04-25
SK287216B6 (sk) 2010-03-08
EA200200776A1 (ru) 2002-12-26
CA2397594A1 (en) 2001-07-26
MXPA02006965A (es) 2004-09-06
IL150643A0 (en) 2003-02-12
DK1252155T3 (da) 2005-04-04
TWI293072B (en) 2008-02-01
EP1252155A1 (en) 2002-10-30
HU225155B1 (en) 2006-07-28
HUP0204297A3 (en) 2005-04-28
CZ20022467A3 (cs) 2002-10-16
JP2003520798A (ja) 2003-07-08
WO2001053294A1 (en) 2001-07-26
AU2001230869A1 (en) 2001-07-31
DE60107652D1 (de) 2005-01-13
CA2397594C (en) 2010-03-23
PL201690B1 (pl) 2009-04-30
EP1252155B1 (en) 2004-12-08
DE60107652T2 (de) 2005-12-22
HUP0204297A2 (hu) 2003-04-28
CN1395577A (zh) 2003-02-05
KR20020069514A (ko) 2002-09-04
BR0107724A (pt) 2002-10-01
NZ520281A (en) 2004-04-30
SI1252155T1 (en) 2005-06-30
EA005182B1 (ru) 2004-12-30
SK10372002A3 (sk) 2002-12-03
NO322626B1 (no) 2006-11-06

Similar Documents

Publication Publication Date Title
AR028567A1 (es) Nuevos derivados de fenil-propargileter
AR028596A1 (es) Nuevos derivados de fenilglicina
IS2192B (is) Setin arýlpýrasín
ATE333445T1 (de) Pyrazolderivate
NO20020930D0 (no) Enkelturs, flerisolerings, brönnfraktureringssystem
ATE441631T1 (de) Phenylpiperidinderivate als serotonin- wiederaufnahmehemmer
NO20013945L (no) Fremstilling av isoflavonderivater
EE05386B1 (et) Ftalasinoon-piperidinoderivaadid,ÁnendeÁkasutamineÁjaÁravim
NO20025151D0 (no) Nye forbindelser
NO20035694D0 (no) Nye sulfonsyrederivater
DK1571140T3 (da) Substituerede C-cyjklohexylmethylamin-derivater
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
PT1351959E (pt) Novos derivados de pleuromutilina
DE60201463D1 (de) Indanon-Derivate als Duftstoffe
NO20023385L (no) Etanolopplösning av (-)-cis-2-(2-klorofenyl)-5,7-dihydroksy- 8(4R-(3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on
DE60110046D1 (de) Cyclische hexapeptidderivate
ATE361274T1 (de) Substituierte 5-amino-1-penten-3-ol-derivate
NO20040913L (no) Nye 2,4-diaminotiazolderivater
NO20004364L (no) Nye saltformer av (2E)-5-amino-5-metylheks-2-ensyre-N-metyl-N-
DK1343806T3 (da) Methylensteroider som nye androgener
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees